4.6 Article

Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls

Journal

GYNECOLOGIC ONCOLOGY
Volume 155, Issue 2, Pages 237-244

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2019.09.002

Keywords

Cervical cancer; Gynecologic cancer; Gut microbiota; Microbiome

Funding

  1. University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment (CRD)
  2. National Institutes of Health (NIH) through MD Anderson's Cancer Center Support Grant [P30CA016672]
  3. National Institutes of Health T32 grant [5T32 CA101642-13]
  4. University of Texas MD Anderson Cancer Center HPV-related Cancers Moonshot

Ask authors/readers for more resources

Objectives: The aim of this study was to characterize variation in the gut microbiome of women with locally advanced cervical cancer and compare it to healthy controls. Methods: We characterized the 16S rDNA fecal microbiome in 42 cervical cancer patients and 46 healthy female controls. Shannon diversity index (SDI) was used to evaluate alpha (within sample) diversity. Beta (between sample) diversity was examined using principle coordinate analysis (PCoA) of unweighted Unifrac distances. Relative abundance of microbial taxa was compared between samples using Linear Discriminant Analysis Effect Size (LEfSe). Results: Within cervical cancer patients, bacterial alpha diversity was positively correlated with age (p = 0.22) but exhibited an inverse relationship in control subjects (p < 0.01). Alpha diversity was significantly higher in cervical cancer patients as compared to controls (p < 0.05), though stratification by age suggested this relationship was restricted to older women (>50 years; p < 0.01). Beta diversity (unweighted Unifrac; p < 0.01) also significantly differed between cervical cancer patients and controls. Based on age- and race-adjusted LEfSe analysis, multiple taxa significantly differed between cervical cancer patients and controls. Prevotella, Porphyromonas, and Dialister were significantly enriched in cervical cancer patients, while Bacteroides, Alistipes and members of the Lachnospiracea family were significantly enriched in healthy subjects. Conclusion: Our study suggests differences in gut microbiota diversity and composition between cervical cancer patients and controls. Associations within the gut microbiome by age may reflect etiologic/clinical differences. These findings provide rationale for further study of the gut microbiome in cervical cancer. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Depressive symptoms and chronic lung disease in middle-aged and older Chinese adults: Prospective bidirectional association and mediation analysis

Jiali Zheng, Jingmeng Li, Tianduo Pei, Tianren Zhu, Io Hong Cheong, Sha Li, Xiaonan Wang, Brian J. Hall, Xiaoguang Li, Hui Wang

Summary: Elevated depressive symptoms and chronic lung disease (CLD) were found to be mutual risk factors in middle-aged and older Chinese adults. Early screening and treatment of depression is necessary to reduce the risk of CLD and related comorbidities, including new-onset depression, and to alleviate the disease burden of CLD and depression in China.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Review Nutrition & Dietetics

The Isocaloric Substitution of Plant-Based and Animal-Based Protein in Relation to Aging-Related Health Outcomes: A Systematic Review

Jiali Zheng, Tianren Zhu, Guanghuan Yang, Longgang Zhao, Fangyu Li, Yong-Moon Park, Fred K. Tabung, Susan E. Steck, Xiaoguang Li, Hui Wang

Summary: Isocaloric substitution of plant-based protein for animal-based protein may have beneficial effects on preventing all-cause and cardiovascular disease-specific mortality, especially when substituting red and processed meat protein. However, more studies are needed, particularly regarding cancer incidence and other specific aging-related diseases.

NUTRIENTS (2022)

Review Nutrition & Dietetics

The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review

Jiali Zheng, Longgang Zhao, Jingwen Dong, Huiyi Chen, Donghui Li, Xuehong Zhang, Manal M. Hassan, Susan E. Steck, Xiaoguang Li, Yong-Bing Xiang, Hui Wang

Summary: Dietary factors play a crucial role in the risk of progression from NAFLD to HCC. Certain dietary patterns or individual foods with anti-inflammatory potential are associated with a reduced risk of NAFLD and HCC.

CLINICAL NUTRITION (2022)

Article Multidisciplinary Sciences

Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy

Julianne K. Bronk, Chiraag Kapadia, Xiaogang Wu, Bhavana Chapman, Rui Wang, Tatiana Karpinets, Xingzhi Song, Andrew M. Futreal, Jianhua Zhang, Ann H. Klopp, Lauren E. Colbert

Summary: This study demonstrates the feasibility and application of a noninvasive swab-based technique for WES analysis, which can be used to investigate dynamic tumor mutational changes during treatment and identify novel genes associated with radiation resistance.

PLOS ONE (2022)

Article Oncology

Association between dietary inflammatory potential and mortality after cancer diagnosis in the Women's Health Initiative

Jiali Zheng, Fred K. Tabung, Jiajia Zhang, Bette Caan, James R. Hebert, Candyce H. Kroenke, Judith Ockene, Nitin Shivappa, Susan E. Steck

Summary: This study examined the association between post-diagnosis dietary inflammatory potential and mortality outcomes among post-menopausal women diagnosed with cancer. It found that a more anti-inflammatory diet plus supplements after a cancer diagnosis was associated with lower all-cause mortality, cancer mortality, and mortality from cardiovascular disease and other causes.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors

A. K. Yoder, D. S. Lakomy, J. Wu, L. M. Andring, B. Fellman, L. E. Colbert, A. Jhingran, A. H. Klopp, P. Soliman, S. K. Peterson, L. L. Lin

Summary: This study aimed to compare the quality of life (QoL) in patients with uterine cancer who underwent surgery with or without radiation therapy. The results showed that there were differences in overall QoL between different treatment groups, with the external beam radiation therapy (EBRT) group reporting the lowest QoL and the brachytherapy group reporting the highest QoL.

CLINICAL ONCOLOGY (2023)

Article Oncology

Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study

Katherine Foster, Katelyn F. Handley, Deanna Glassman, Travis T. Sims, Sanaz Javadi, Sarah M. Palmquist, Mohammed M. Saleh, Bryan M. Fellman, Nicole D. Fleming, Priya R. Bhosale, Anil K. Sood

Summary: By analyzing CT scans and laparoscopic assessments of 109 patients with high-grade serous ovarian cancer, radiographic features unique to each morphologic subtype were identified, including large infiltrative plaques, mass-like metastases, and enhancing peritoneal lining. These findings provide valuable insights for the accurate diagnosis and classification of high-grade serous ovarian cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

Lauren E. Colbert, Molly B. El Alam, Rui Wang, Tatiana Karpinets, David Lo, Erica J. Lynn, Timothy A. Harris, Jacob H. Elnaggar, Kyoko Yoshida-Court, Katarina Tomasic, Julianna K. Bronk, Julie Sammouri, Ananta Yanamandra, Adilene Olvera, Lily G. Carlin, Travis Sims, Andrea Y. Delgado Medrano, Tatiana Cisneros Napravnik, Madison O'Hara, Daniel Lin, Chike O. Abana, Hannah X. Li, Patricia J. Eifel, Anuja Jhingran, Melissa Joyner, Lilie Lin, Lois M. Ramondetta, Andrew M. Futreal, Kathleen M. Schmeler, Geena Mathew, Stephanie Dorta-Estremera, Jianhua Zhang, Xiaogang Wu, Nadim J. Ajami, Matthew Wong, Cullen Taniguchi, Joseph F. Petrosino, K. Jagannadha Sastry, Pablo C. Okhuysen, Sara A. Martinez, Lin Tan, Iqbal Mahmud, Philip L. Lorenzi, Jennifer A. Wargo, Ann H. Klopp

Summary: The tumor microbiota, specifically lactate-producing lactic acid bacteria, can affect tumor metabolism and lactate signaling pathways, leading to therapeutic resistance in various cancers. These findings suggest that lactate-producing lactic acid bacteria could be potential therapeutic targets across different types of cancer.

CANCER CELL (2023)

Meeting Abstract Oncology

Ten-year clinical outcomes of stage IVA cervical cancer by bladder involvement treated with definitive chemoradiation

Julie Sammouri, Aradhana Venkatesan, Ann Klopp, Lilie Lin, Anuja Jhingran, Melissa Joyner, Patricia Eifel, Lauren Colbert

GYNECOLOGIC ONCOLOGY (2023)

Article Nutrition & Dietetics

Associations of Dietary Inflammatory Potential with Esophageal Precancerous Lesions and Esophageal Squamous-Cell Cancer: A Cross-Sectional Study

Jingwen Dong, Min Gao, Lin Li, Xiaoyu Pan, Sheng-Yin Chen, Jun Li, Stephanie A. Smith-Warner, Xiaoguang Li, Hui Wang, Jiali Zheng

Summary: This study examined the relationship between the overall inflammatory potential of diets and esophageal precancerous lesions (EPLs) and esophageal squamous-cell cancer (ESCC). The study found a positive association between the inflammatory potential of diets and the odds of EPLs and ESCC. Consuming anti-inflammatory foods may be beneficial in preventing EPLs and ESCC.

NUTRIENTS (2023)

Meeting Abstract Oncology

Impact of Para-Aortic Lymph Node Count on Survival in Patients with Cervical Cancer and Para-Aortic Lymph Node Involvement Treated with Definitive Radiation Therapy

A. Seo, D. S. Lakomy, L. Colbert, A. Jhingran, M. M. Joyner, A. H. Klopp, L. Meyer, P. J. Eifel, L. L. Lin

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Tumor Microbiome Composition in Vaginal and Vulvar Cancers during Chemoradiation

K. Tomasic, M. B. El Alam, D. Lin, T. Karpinets, E. J. Lynn, A. Olvera, N. J. Ajami, L. L. Lin, A. Jhingran, P. J. Eifel, M. M. Joyner, P. Okhuysen, C. M. Taniguchi, A. H. Klopp, L. Colbert

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Characterization of the Tumor-Associated Microbiome Landscapes of HPV-Related Anogenital Cancers

M. B. El Alam, K. Tomasic, D. Lin, T. Karpinets, E. J. Lynn, A. Olvera, N. J. Ajami, L. L. Lin, A. Jhingran, P. J. Eifel, M. M. Joyner, P. Okhuysen, C. M. Taniguchi, A. H. Klopp, L. Colbert

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Baseline Characteristics of Patients Undergoing Brachytherapy for Gynecologic Cancer (GYN-BT) and the Role for an Enhanced Recovery Pathway (ERP)

L. M. Andring, C. Kelsey, J. Weng, G. S. Manzar, N. Bailard, B. Fellman, M. Domingo, J. Varkey, T. Foster-Mills, T. Kazantsev, L. L. Lin, A. Jhingran, L. Colbert, P. J. Eifel, A. H. Klopp, M. M. Joyner

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

A new machine learning-based clinical tool for vertebral level verification and treatment planning

T. Netherton, C. Nguyen, C. Cardenas, C. Chung, A. Klopp, L. Colbert, D. J. Rhee, C. Peterson, R. Howell, A. Aggarwal, H. Simonds, L. Court

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions

Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko

Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.

GYNECOLOGIC ONCOLOGY (2024)